SSStephanie L. Santoro

Stephanie L. Santoro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stephanie L. Santoro has a total of 268 co-authors. Here are the top co-authors by number of shared publications:

  • Amy Torres

    Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics Massachusetts General Hospital Boston Massachusetts USA

    18 shared publications
  • Brian G. Skotko

    Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA

    16 shared publications
  • Nicolas Michel Oreskovic

    Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics Massachusetts General Hospital Boston Massachusetts USA

    13 shared publications
  • Kelsey Haugen

    Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, MA

    9 shared publications
  • Clorinda Cottrell

    Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics Massachusetts General Hospital Boston Massachusetts USA

    8 shared publications
  • Brian G. Skotko

    Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA

    7 shared publications

Latest Publications

  • Open Access

    Use of Electroconvulsive Therapy for Catatonia in Down Syndrome Regression Disorder: A Systematic Review, Case Series, and Analysis

    by Seri Lim, Kaidi Kang, Elizabeth Oey, Stephanie Santoro, Catherine Franklin, James Luccarelli, Rafael Tamargo, Courtney Hamilton, Sarah Marler, Timothy Adegoke, et al.

    Purpose: Down syndrome regression disorder (DSRD) is a condition occurring in young people with Down syndrome. It is associated with functional decline, new onset psychopathology, and increased support needs. DSRD is often associated with catatonia, for which electroconvulsive therapy (ECT) is an effective treatment. However, there are scant studies to guide best practice in this area. Methods: We report a case series of 5 patients who have received ECT at Vanderbilt University Medical Center. A systematic review and analysis were conducted, combining this case series with previously reported data in the literature. Results: This analysis included data from 27 patients, 5 from the VUMC case series and a further 22 from 14 studies. Combining all patients from case series and the systematic review, there were 17 pre-ECT and 15 post-ECT Bush Francis Catatonia Rating Scale (BFCRS) scores reported from 7 sites/studies. The mean pre-ECT BFCRS score from all patients was 17.40 (SD = 5.72) and the mean post-ECT BFCRS score was 4.40 (SD = 5.26). A generalized estimating equations analysis revealed that there was a significant difference in the expected BFCRS score before and after receiving ECT treatment ( β = -13.00 with 95%, p < 0.001), suggesting that the ECT treatment had a significant effect on reducing the BFCRS scores. No severe adverse events were reported. Conclusion: ECT is associated with clinical improvement in patients with catatonia in the context of DSRD in this systematic review and analysis. More research is needed to provide a more robust evidence base.

  • The Prevalence of Co‐Occurring Conditions and an Exploration of Social Factors Influencing Health in Down Syndrome

    by Mary E. Witt, Chengbo Zeng, Stephanie L. Santoro

    Measuring health, a state of complete physical, mental, and social well‐being and not merely the absence of disease or infirmity, in Down syndrome (DS) was recently achieved through creation of a new health measure. However, additional information on health‐related medical topics and how health measurement varies in demographic groups from that cohort has not been presented. We surveyed caregivers of individuals age 0–21 with Down syndrome (DS) from a national sample about the health of their son or daughter with DS as part of a broader study to create a valid, reliable health measure in DS. In this manuscript, we present secondary analysis of survey items on health‐related topics including co‐occurring medical conditions, recurrent infections, and healthcare maintenance. We then conducted an analysis to compare caregiver‐reported demographic traits to total health scores through regression modeling to identify predictors of health status. Survey responses from 542 caregivers of individuals with DS were received; rates of co‐occurring medical conditions generally aligned with past results, rates of recurrent infections showed lower rates of persistent fungal infections in our cohort ( p < 0.0001) and completion of healthcare guidelines did not correlate with health scores ( p = 0.13). In regression modeling, parent sex of respondent (male) and better parent health correlated with better total health scores of individuals with DS. Health‐related topics show prevalence rates aligning with past literature, lower rates of some infections, and imperfect guideline adherence. Fathers and parents who feel that they are in better health reported better health of their sons and daughters with DS. Trial Registration: ClinicalTrials.gov , NCT04631237

  • Open Access

    Down Syndrome Births Among Live Births from the CDC Wonder Database

    by Stephanie L. Santoro, Chance Alvarado, Stephen A. Hart, Thomas Casto, Clifford L. Cua

    We evaluated the birth rate of Down syndrome (DS) in the CDC birth certificate online database. From 2016 to 2025, live birth incidence could range greatly (depending on the proportion of unknown cases that are counted as DS+) due to relatively high numbers of unknown/not stated status. The annual live birth incidence of DS in live-born infants using CDC birth certificate data from 2016 to 2025 shows a wide range of potential birth rates as calculated here, due to relatively high numbers of unknown/not stated DS status. Although our findings overlap with published data, future studies are needed to further evaluate the current birth rate of DS in the US.

  • Open Access

    Down syndrome birth rate post Dobbs decision: has it changed?

    by Stephanie L. Santoro, Chance Alvarado, Stephanie Y. Tseng, Sara Conroy, Isaac Kistler, Stephen A. Hart, Samantha Fichtner, Clifford L. Cua

    Objective: In 2022, the U.S. Supreme Court decision on Dobbs v. Jackson Women’s Health Organization changed abortion access. We evaluated birth rates of Down syndrome (DS) before and after the Dobbs decision hypothesizing similarity to cyanotic congenital heart disease. Study design: Retrospective cohort study of live births utilizing 2016 – 2025 CDC birth certificate registry data stratified by DS and by state abortion access categories (restrictive and protective) based on the Guttmacher Institute. Incidence of DS and the difference in incidence between state cohorts were modeled and compared between pre- and post-Dobbs periods using segmented linear regression. Results: Incidence of DS live births remained stable in restrictive and protective states pre- and post-Dobbs. Segmented regression models revealed no significant changes in monthly incidence in the post-Dobbs era nationally compared to pre-Dobbs. Conclusions: Mean monthly incidence of DS in live-born infants using CDC birth certificate data did not increase after the Dobbs decision.


  • Caregivers' Perspectives on Medical Management and Its Helpfulness in Down Syndrome

    by Kavita Krell, Mary Witt, Stephanie L. Santoro

    The World Health Organization defines health as “a state of complete physical, mental, and social well‐being and not merely the absence of disease or infirmity.” Medical interventions are often studied for effectiveness in carefully controlled clinical trials, but the parent‐perceived, real‐world helpfulness of medical management steps on health is less studied. As part of a broader study to create a valid, reliable health measure in DS, we surveyed caregivers of individuals aged 0–21 with Down syndrome (DS) about activities that were helpful for managing their children's health. From February 2023 to February 2024, we received 542 complete survey responses from a national sample. We present caregiver‐reported information on actions that caregivers perceived as helpful to address medical conditions in individuals with DS, medical providers seen, and correlations with general health status. Caregiver reports revealed variable health management actions and diverse perceived helpfulness across health domains. Certain actions for constipation prevention and mental health management correlated with higher overall health scores. The utilization of primary care providers and specialists highlights the importance of interprofessional care and communication. Trial Registration: ClinicalTrials.gov : NCT04631237


  • The Detection of Down Syndrome Arthritis in Clinical Practice: A Multicenter, International Pilot and Feasibility Study of a Down Syndrome‐Specific Musculoskeletal Screening Tool

    by Jordan T. Jones, Nasreen Talib, Emily Cramer, Diletta Valentini, Nicole Baumer, Sabrina Sargado, Nicolas M. Oreskovic, Stephanie L. Santoro, Kavita Krell, Jonathan D. Santoro, et al.

    Down syndrome (DS) is associated with an increased risk for an inflammatory arthritis termed Down syndrome‐associated arthritis (DA). Clinical awareness of DA may prevent morbidity, but there is currently no consensus approach to screen for DA. A DS musculoskeletal (DS‐MSK) screening tool was developed and piloted in clinics to identify inflammatory arthritis in individuals with DS. The prevalence of DA and the feasibility of the DS‐MSK screening tool were also evaluated. Through a non‐randomized, cross‐sectional, multicenter study, patients with DS were enrolled by eight institutions that provide specialized comprehensive care to individuals with DS. A novel tool was developed to screen all patients for DA through DS‐MSK history and DS‐physical exam. Feasibility was assessed through the assessment of additional time the screening tool added to clinical visits. Of the 1111 participants with an average age of 10 years (SD 6.7), there were 1019 pediatric patients and 92 adult patients. There were 62 (6%) positive screens; of those, 21 (34%) were diagnosed with DA by a rheumatologist. Reports of joint swelling, redness, warmth, and stiffness were most associated with a diagnosis of DA. DA is an important consideration in the comprehensive care of individuals with DS. The condition can be aggressive and debilitating if misdiagnosed. We developed a simple, feasible DS‐MSK screening tool that can identify DA. Future studies should focus on a shorter, less time‐consuming tool that maintains positive predictive value for diagnosing DA that can easily be implemented into routine care for people with DS.


  • Development and Validation of a Health Measure for Down Syndrome

    by Stephanie L. Santoro, Ashlee Campbell, Maria Cabrera, John Patrick T. Co, Karen Donelan, Kelsey Haugen, Kavita Krell, Mikayla Shaffer, Brian G. Skotko, Jonathan P. Winickoff, et al.


  • Daily Activities, Exercise and Endurance in Down Syndrome

    by Stephanie L. Santoro, Dominica Nichols, Mary Witt, Nicolas M. Oreskovic

    Given the increased prevalence of overweight and obesity in Down syndrome (DS) and known barriers to exercise and physical activity, we surveyed caregivers on these topics in a health survey. We aimed to explore how different daily activities, exercise and endurance contribute to overall health status in DS. As part of a broader study creating a valid, reliable health measure in DS, we surveyed caregivers of individuals ages 0–21 with DS. This study summarizes descriptive statistics (mean, frequencies, distributions) on survey item responses related to daily activities, exercise, and endurance. We compared 56 item level responses to overall health score through point‐biserial or Spearman correlation coefficients. From February 2023 to February 2024, we received 542 complete survey responses from a nationally‐represented sample. We present caregiver‐reported information on daily activities and exercise, and demonstrate that caregivers perceive individuals with DS to have difficulty with endurance (keeping up with peers, keeping up with family and running same distance as peers). Thirty‐five correlations were significant at Bonferroni corrected p < 0.00089; better health correlated with increased endurance, increased engagement, higher physical activity level, among others. Increased support of accessible programming is one way to accomplish health goals through increased exercise and engagement. Future work is needed to better understand caregiver‐perceived endurance of their sons and daughters with DS. Trial Registration: Clinical Trials Number: NCT04631237; https://clinicaltrials.gov/study/NCT04631237 .


  • The International Summit on Health Benefits of Physical Fitness for People With Down Syndrome: Current Science, Gaps, Priorities, and Research Opportunities

    by Nicolas M. Oreskovic, Greg Austin, Brendan Aylward, Pieter Boer, Véronique‐A Bricout, Nashwa Cheema, Amit Das, Bo Fernhall, Richard Fleming, Carolina Florez, et al.

    The summary paper reports on and highlights the scientific discussions and development process for new expert‐recommended physical fitness guidelines for individuals with Down syndrome that occurred at the inaugural International Summit on Health Benefits of Physical Fitness for People with Down Syndrome (ISFDS). The Summit was a two‐day event held in May 2025 at the Massachusetts General Hospital in Boston that brought together leading international scientists, clinicians, self‐advocates, community services and industries, and local and national advocacy organizations to discuss the latest research, therapies, and collaborative opportunities in physical fitness for individuals with Down syndrome. Day 1 focused on the current state of the science and the identification of research gaps; Day 2 featured working groups dedicated to developing collaborations, planning future research, and creating expert clinical guidelines on physical fitness in children and adults with Down syndrome using a Delphi approach.


  • Caregiver Interviews Regarding Health in Down Syndrome

    by Mary Witt, Kavita Krell, Stephanie L. Santoro

    Individuals with Down syndrome (DS) have co‐occurring medical conditions. Research on how caregivers understand, interpret, and answer questions about the health of their son or daughter with DS is needed to guide the development of a measure of the health status of children and adolescents with DS. We conducted 1‐h virtual cognitive interviews of caregivers of individuals aged 0 to 21 with DS about our drafted survey items on physical, mental, and social health using a modified “think‐aloud” approach with probes. In addition to using their feedback to iteratively refine our survey, in this manuscript we describe the themes of feedback from caregivers and summarize survey item changes. Four rounds of cognitive interviews for a total of 40 interviews of 42 caregivers of individuals with DS were completed. Cognitive interview themes included: using the easiest phrase possible, focusing on the present, being conversational in terminology, and specifying who items refer to or who comparison groups are, among others. Caregiver interviews were informative and led us to make modifications to our survey items. Themes emerged which hold use to other researchers conducting surveys in populations with genetic syndromes. Trial Registration: NCT04631237